more general categories |
information about this item |
|
1. Human Genes |
 |
 |
|
1. Human Genes |
|
|
cytochrome P450, family 01, subfamily A, polypeptide 02 [HGNC:CYP1A2] (466) |
|
|
cytochrome P450, family 02, subfamily C, polypeptide 19 [HGNC:CYP2C19] (172) |
|
|
cytochrome P450, family 02, subfamily D, polypeptide 06 [HGNC:CYP2D6] (200) |
|
|
cytochrome P450, family 03, subfamily A, polypeptide 04 [HGNC:CYP3A4] (612) |
|
 |
2. Interaction: Human Genes and Chemicals |
 |
 |
|
2. Interaction: Human Genes and Chemicals |
|
|
activity (2865) |
|
 |
C02. Virus Diseases |
 |
 |
|
C02. Virus Diseases |
|
|
|
|
|
Hepatitis C [MESH:D006526] (1627) |
|
|
|
|
|
Hepatitis C [MESH:D006526] (1627) |
|
 |
C04. Neoplasms |
 |
 |
|
C04. Neoplasms |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Osteosarcoma [MESH:D012516] (2175) |
|
|
Osteosarcoma [MESH:D012516] (2175) |
|
|
|
|
|
Carcinoma, Squamous Cell [MESH:D002294] (4294) |
|
|
Carcinoma, Squamous Cell [MESH:D002294] (4294) |
|
|
Breast Neoplasms [MESH:D001943] (6077) |
|
|
|
|
|
|
|
|
Colorectal Neoplasms [MESH:D015179] (5294) |
|
|
Liver Neoplasms, Experimental [MESH:D008114] (2837) |
|
|
|
|
|
Lung Neoplasms [MESH:D008175] (6015) |
|
|
|
|
|
Prostatic Neoplasms [MESH:D011471] (6135) |
|
|
Urinary Bladder Neoplasms [MESH:D001749] (4079) |
|
|
Liver Neoplasms, Experimental [MESH:D008114] (2837) |
|
 |
C05. Musculoskeletal Diseases |
 |
 |
|
C05. Musculoskeletal Diseases |
|
|
|
|
|
Muscle Rigidity [MESH:D009127] (617) |
|
 |
C06. Digestive System Diseases |
 |
 |
|
C06. Digestive System Diseases |
|
|
|
|
|
|
|
|
|
|
|
Colorectal Neoplasms [MESH:D015179] (5294) |
|
|
Liver Neoplasms, Experimental [MESH:D008114] (2837) |
|
|
|
|
|
|
|
|
Colorectal Neoplasms [MESH:D015179] (5294) |
|
|
|
|
|
Colorectal Neoplasms [MESH:D015179] (5282) |
|
|
Colorectal Neoplasms [MESH:D015179] (5294) |
|
|
Colorectal Neoplasms [MESH:D015179] (4534) |
|
|
Drug-Induced Liver Injury [MESH:D056486] (4936) |
|
|
Hepatomegaly [MESH:D006529] (1169) |
|
|
|
|
|
Hepatitis C [MESH:D006526] (1627) |
|
|
Liver Cirrhosis, Experimental [MESH:D008106] (4589) |
|
|
Liver Neoplasms, Experimental [MESH:D008114] (2837) |
|
|
Porphyria Cutanea Tarda [MESH:D017119] (766) |
|
 |
C08. Respiratory Tract Diseases |
 |
 |
|
C08. Respiratory Tract Diseases |
|
|
|
|
|
Lung Injury [MESH:D055370] (3688) |
|
|
Lung Neoplasms [MESH:D008175] (6012) |
|
|
Pulmonary Disease, Chronic Obstructive [MESH:D029424] (3564) |
|
|
Lung Neoplasms [MESH:D008175] (6013) |
|
 |
C10. Nervous System Diseases |
 |
 |
|
C10. Nervous System Diseases |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Parkinson Disease [MESH:D010300] (3595) |
|
|
Alzheimer Disease [MESH:D000544] (4275) |
|
|
|
|
|
Epilepsy, Tonic-Clonic [MESH:D004830] (1042) |
|
|
|
|
|
Parkinson Disease [MESH:D010300] (3595) |
|
|
Neural Tube Defects [MESH:D009436] (2143) |
|
|
Parkinson Disease [MESH:D010300] (3595) |
|
|
Alzheimer Disease [MESH:D000544] (4275) |
|
|
|
|
|
Dystonia [MESH:D004421] (848) |
|
|
Tremor [MESH:D014202] (840) |
|
|
|
|
|
|
|
|
Coma [MESH:D003128] (524) |
|
|
|
|
|
Muscle Rigidity [MESH:D009127] (617) |
|
|
Peripheral Nervous System Diseases [MESH:D010523] (6151) |
|
|
|
|
|
Manganese Poisoning [MESH:D020149] (2214) |
|
 |
C12. Male Urogenital Diseases |
 |
 |
|
C12. Male Urogenital Diseases |
|
|
|
|
|
|
|
|
Prostatic Neoplasms [MESH:D011471] (6135) |
|
|
Prostatic Neoplasms [MESH:D011471] (6135) |
|
|
|
|
|
Prostatic Neoplasms [MESH:D011471] (6135) |
|
|
Urinary Bladder Neoplasms [MESH:D001749] (4079) |
|
|
|
|
|
|
|
|
Nephritis, Interstitial [MESH:D009395] (1927) |
|
|
Acute Kidney Injury [MESH:D058186] (4142) |
|
|
Kidney Failure, Chronic [MESH:D007676] (2930) |
|
|
Urinary Bladder Neoplasms [MESH:D001749] (4079) |
|
 |
C13. Female Urogenital Diseases and Pregnancy Complications |
 |
 |
|
C13. Female Urogenital Diseases and Pregnancy Complications |
|
|
|
|
|
|
|
|
|
|
|
Primary Ovarian Insufficiency [MESH:D016649] (270) |
|
|
|
|
|
Urinary Bladder Neoplasms [MESH:D001749] (4079) |
|
|
|
|
|
|
|
|
Nephritis, Interstitial [MESH:D009395] (1927) |
|
|
Acute Kidney Injury [MESH:D058186] (4142) |
|
|
Kidney Failure, Chronic [MESH:D007676] (2930) |
|
|
Urinary Bladder Neoplasms [MESH:D001749] (4079) |
|
|
|
|
|
Prenatal Exposure Delayed Effects [MESH:D011297] (870) |
|
 |
C14. Cardiovascular Diseases |
 |
 |
|
C14. Cardiovascular Diseases |
|
|
Not Fully Specified [NFS] (2667) |
|
|
|
|
|
|
|
|
Bradycardia [MESH:D001919] (1899) |
|
|
|
|
|
Torsades de Pointes [MESH:D016171] (880) |
|
|
|
|
|
Thrombosis [MESH:D013927] (3101) |
|
 |
C15. Hemic and Lymphatic Diseases |
 |
 |
|
C15. Hemic and Lymphatic Diseases |
|
|
Methemoglobinemia [MESH:D008708] (850) |
|
|
Splenic Diseases [MESH:D013158] (1323) |
|
 |
C16. Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
 |
 |
|
C16. Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
|
|
|
|
|
|
|
|
Neural Tube Defects [MESH:D009436] (2143) |
|
|
|
|
|
Drug Metabolism, Poor, CYP2C19-Related [MESH:C563703] (182) |
|
|
Drug Metabolism, Poor, CYP2D6-Related [MESH:C563835] (220) |
|
|
|
|
|
Porphyria Cutanea Tarda [MESH:D017119] (766) |
|
|
|
|
|
Porphyria Cutanea Tarda [MESH:D017119] (766) |
|
 |
C17. Skin and Connective Tissue Diseases |
 |
 |
|
C17. Skin and Connective Tissue Diseases |
|
|
|
|
|
Breast Neoplasms [MESH:D001943] (6077) |
|
|
|
|
|
Porphyria Cutanea Tarda [MESH:D017119] (766) |
|
|
|
|
|
|
|
|
Porphyria Cutanea Tarda [MESH:D017119] (766) |
|
 |
C18. Nutritional and Metabolic Diseases |
 |
 |
|
C18. Nutritional and Metabolic Diseases |
|
|
|
|
|
|
|
|
Diabetes Mellitus, Type 2 [MESH:D003924] (4219) |
|
|
Drug Metabolism, Poor, CYP2C19-Related [MESH:C563703] (182) |
|
|
Drug Metabolism, Poor, CYP2D6-Related [MESH:C563835] (220) |
|
|
|
|
|
Porphyria Cutanea Tarda [MESH:D017119] (766) |
|
|
|
|
|
Porphyria Cutanea Tarda [MESH:D017119] (766) |
|
|
|
|
|
|
|
|
Porphyria Cutanea Tarda [MESH:D017119] (766) |
|
 |
C19. Endocrine System Diseases |
 |
 |
|
C19. Endocrine System Diseases |
|
|
|
|
|
Diabetes Mellitus, Type 2 [MESH:D003924] (4219) |
|
|
|
|
|
Primary Ovarian Insufficiency [MESH:D016649] (270) |
|
 |
C23. Pathological Conditions, Signs and Symptoms |
 |
 |
|
C23. Pathological Conditions, Signs and Symptoms |
|
|
Atrophy [MESH:D001284] (2603) |
|
|
Hepatomegaly [MESH:D006529] (1169) |
|
|
Splenomegaly [MESH:D013163] (1258) |
|
|
Growth Disorders [MESH:D006130] (2438) |
|
|
Bradycardia [MESH:D001919] (1899) |
|
|
|
|
|
Torsades de Pointes [MESH:D016171] (880) |
|
|
|
|
|
|
|
|
Weight Gain [MESH:D015430] (2595) |
|
|
|
|
|
Dystonia [MESH:D004421] (848) |
|
|
Tremor [MESH:D014202] (840) |
|
|
|
|
|
|
|
|
Coma [MESH:D003128] (492) |
|
|
|
|
|
Muscle Rigidity [MESH:D009127] (617) |
|
 |
C24. Occupational Diseases |
 |
 |
|
C24. Occupational Diseases |
|
|
Occupational Diseases [MESH:D009784] (3402) |
|
|
Not Fully Specified [NFS] (1530) |
|
 |
C25. Chemically-Induced Disorders |
 |
 |
|
C25. Chemically-Induced Disorders |
|
|
Drug-Induced Liver Injury [MESH:D056486] (4936) |
|
|
Drug-Induced Liver Injury [MESH:D056486] (4936) |
|
|
Manganese Poisoning [MESH:D020149] (2214) |
|
|
Amphetamine-Related Disorders [MESH:D019969] (2858) |
|
 |
C26. Wounds and Injuries |
 |
 |
|
C26. Wounds and Injuries |
|
|
|
|
|
Lung Injury [MESH:D055370] (1814) |
|
 |
D02. Organic Chemicals |
 |
 |
|
D02. Organic Chemicals |
|
|
|
|
|
Terpenes [MESH:D013729] (10347) |
|
 |
D27. Chemical Actions and Uses |
 |
 |
|
D27. Chemical Actions and Uses |
|
|
|
|
|
Antineoplastic Agents [MESH:D000970] (319) |
|
 |